U.S. Markets open in 3 hrs 22 mins
  • S&P Futures

    4,250.25
    +4.50 (+0.11%)
     
  • Dow Futures

    34,490.00
    +28.00 (+0.08%)
     
  • Nasdaq Futures

    14,030.00
    +35.75 (+0.26%)
     
  • Russell 2000 Futures

    2,333.50
    -0.40 (-0.02%)
     
  • Crude Oil

    71.45
    +0.54 (+0.76%)
     
  • Gold

    1,860.10
    -19.50 (-1.04%)
     
  • Silver

    27.87
    -0.28 (-0.98%)
     
  • EUR/USD

    1.2117
    +0.0010 (+0.0848%)
     
  • 10-Yr Bond

    1.4620
    0.0000 (0.00%)
     
  • Vix

    15.92
    -0.18 (-1.12%)
     
  • GBP/USD

    1.4093
    -0.0023 (-0.1635%)
     
  • USD/JPY

    109.6710
    +0.0360 (+0.0328%)
     
  • BTC-USD

    39,183.95
    +3,415.17 (+9.55%)
     
  • CMC Crypto 200

    975.46
    +33.64 (+3.57%)
     
  • FTSE 100

    7,166.11
    +32.05 (+0.45%)
     
  • Nikkei 225

    29,161.80
    +213.07 (+0.74%)
     

How Big Is Pfizer's Vaccine Opportunity in India?

·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Pfizer (NYSE: PFE) and its partner BioNTech (NASDAQ: BNTX) are hoping to have an opportunity to win authorization for their COVID-19 vaccine in India. In this Motley Fool Live video recorded on May 5, Motley Fool contributors Keith Speights and Brian Orelli discuss just how big Pfizer's opportunity in India could be. Keith Speights: Pfizer ticker, there's P-F-E. Pfizer announced earlier this week that it's talking with the government of India about a potential accelerated pathway to authorization for its COVID-19 vaccine.